The European Commission has authorized the use of Rinvoq for children aged two and older suffering from active polyarticular juvenile idiopathic arthritis. This approval introduces a new weight-based oral solution for patients who have failed to respond to standard disease-modifying anti-rheumatic drugs, marking a significant expansion for the medication.
The traditional sports broadcast is losing its monopoly on fan attention, a shift that will take center stage at Marketecture Live in Chicago on September 23. Joe Ochoa, co-founder of Creator TV, joins a panel of industry experts to dissect how creators are reshaping the modern sports landscape.
Temu has signed a Memorandum of Understanding with the Association of Business Service Leaders in Romania, marking a strategic pivot to embed its operations within the country's local business ecosystem. The deal positions the e-commerce giant to engage directly with a network ranging from startups to multinational corporations.
Volvo Cars has become the lead industry partner for Horizon, a new open-source platform developed by Accenture and Google Cloud. The collaboration aims to streamline the creation, testing, and deployment of Android Automotive Operating System software, allowing the automaker to replace legacy workflows with cloud-native virtual environments.
China Medical University Hospital has secured a spot on Newsweek’s World’s Best Specialized Hospitals 2027 list for neurosurgery, marking the first time a Taiwanese institution has entered this specific global ranking. The hospital joins an elite group of 125 facilities recognized for excellence in complex neurological care and innovation.
Anyang Indorama Gases has finalized a 2.4 billion RMB, or approximately 358 million USD, long-term loan facility to fund a major fertilizer production expansion in Henan Province. The capital injection marks a strategic pivot for the Singapore-based subsidiary as it looks to double its domestic urea output by 2029.
Corvex Management has requisitioned a general meeting of Whitbread PLC shareholders to appoint partner James Gemmel to the company’s board. As the hospitality firm's largest active shareholder, holding a 7% economic interest, the investment firm argues that direct representation is necessary to address years of underperformance and stagnant returns.
Warsaw-based ExploRNA Therapeutics is joining forces with the Łukasiewicz Industrial Chemistry Institute to transition its proprietary mRNA capping technology into Good Manufacturing Practice production, a move designed to secure the supply chain for clinical-stage mRNA vaccines and advanced genetic medicines.
Warsaw-based biotech firm ExploRNA Therapeutics has joined forces with the Łukasiewicz Industrial Chemistry Institute to transition its proprietary mRNA cap analogs, including the AvantCap Q1 technology, into Good Manufacturing Practice production, bridging the gap between laboratory-scale innovation and the requirements of late-stage clinical trials.
Stockholm-based hygiene and health giant Essity plans to release its financial results for the third quarter of 2026 on October 22. The company will host a live webcast and teleconference at 09:00 CET, two hours after the official publication of the report, to walk investors through the performance metrics.
As European Mobility Week concludes, Breda University of Applied Sciences researchers warn that the surge of light electric vehicles—from e-cargo bikes to fatbikes—threatens traditional cycle path safety. While these vehicles promise to reduce car dependency, they introduce new speed and mass variables that complicate the Netherlands' established infrastructure.
As European Mobility Week concludes, Breda University of Applied Sciences researchers warn that light electric vehicles are testing the limits of Dutch cycling infrastructure. While e-scooters and fatbikes offer a path to lower car dependency, their integration into narrow cycle lanes is driving a measurable increase in safety concerns.
Investors who purchased UWM Holdings Corporation shares between March 9 and August 5, 2026, are being urged to join a class action lawsuit. Schall, Brown & Schwartz LLP claims the mortgage lender misled shareholders by concealing the extent of risks associated with its aggressive hedge position on mortgage servicing rights.
Investors who purchased UWM Holdings Corporation stock between March 9 and August 5, 2026, face an October 13 deadline to join a class action lawsuit. The litigation alleges the mortgage lender misled shareholders by abandoning its core strategy of avoiding hedges on mortgage servicing rights, resulting in undisclosed financial risks.
A fresh $84 million contract puts Swedish construction giant Skanska at the helm of a massive data center expansion in Georgia. The project, commissioned by an existing client, marks a significant addition to the company’s third-quarter order bookings for 2026 as demand for high-capacity digital infrastructure continues to surge.
Investors who held Alarum Technologies Ltd. stock between March 20, 2025, and July 2, 2026, face an October 5 deadline to join a class action lawsuit. The litigation, spearheaded by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the operational practices of its NetNut subsidiary.
Investors who purchased ARS Pharmaceuticals stock between March 9 and June 24, 2026, face a critical October 5 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the timeline for critical formulary and coverage approvals for its product, neffy.
Investors who purchased ARS Pharmaceuticals stock between March 9 and June 24, 2026, face an October 5 deadline to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the insurance coverage timeline for its product, neffy.
In a controlled laboratory setting at Texas A&M University, researchers have completed the initial validation phase for Hylenr’s BRT-NiUCS-2 reactor. The study confirmed anomalous thermal performance and distinct noble-gas signatures within the lattice-based system, marking a departure from internal testing toward independent verification of the technology’s energy potential.
Investors who held Capricor Therapeutics stock between October 9, 2024, and July 10, 2025, are being recruited for a class action lawsuit. The DJS Law Group alleges the biotech firm misled shareholders regarding the clinical progress and safety data of its deramiocel drug candidate during the HOPE-2 trial.
Investors who purchased Datavault AI Inc. stock between September 4, 2024, and October 30, 2025, are being recruited for a class action lawsuit. The DJS Law Group alleges the company misled shareholders by inflating the value of its partnerships and misrepresenting trading volumes on its proprietary platform.
The United States Patent and Trademark Office has officially allowed BiomeRenewables’ application for its FeatherEdge technology, a design that mimics the silent flight of an owl to dampen turbine noise. This patent adds a critical layer of protection to the Toronto-based startup’s expanding intellectual property portfolio.
/kalakaumudi/media/media_files/uBrzqeG4z8BQxxYVU344.JPG)
Between July 17, 2023, and May 26, 2026, HDFC Bank allegedly misled shareholders by obscuring interest payments as marketing expenses. The DJS Law Group has initiated a class action lawsuit under the Securities Exchange Act of 1934, citing violations of federal regulations that demand transparency in corporate financial reporting.
A federal class action lawsuit now challenges Datavault AI Inc. for allegedly disseminating misleading information to shareholders between September 2024 and October 2025. The litigation, spearheaded by Schall, Brown & Schwartz LLP, centers on claims that the company inflated the value of its corporate partnerships and obscured critical operational data.
Investors who held Rackspace Technology shares between May 7 and July 8, 2026, face a looming September 28 deadline to join a class action lawsuit. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to represent shareholders following allegations that the company misled the market regarding its enterprise AI business pivot.
A celebrity kickball game and wellness festival will take over Palm Springs Power Stadium on October 10, 2026, as the Law Offices of Eric A. Rudolph joins as a primary sponsor for Boo2Bullying’s fourth annual "Kick Bullying to the Curb" event to promote community inclusion and youth advocacy.
Suzhou-based BoomRay Pharmaceuticals has secured an exclusive global licensing deal with Novartis for an undisclosed preclinical radioligand therapy. The agreement, potentially worth up to USD 900 million in milestone payments and royalties, marks a major expansion of the Swiss pharmaceutical giant’s precision oncology pipeline.
A staggering $350 billion in global demand remains unmet as the longevity industry ignores the specific health needs of women in perimenopause and menopause. While these consumers are already the most active participants in the market, they remain largely dissatisfied with current offerings, signaling a massive failure in product development.
The Massachusetts Institute of Technology has claimed the No. 1 spot among National Universities in the U.S. News & World Report 2027 Best Colleges rankings, ending Princeton University’s 15-year reign. The shift reflects a significant methodological overhaul prioritizing post-graduate earnings over traditional metrics like student debt.
Mountain View-based xTool has transformed its Atomm platform into an AI-driven creation suite designed to bridge the gap between digital concepts and physical production. By enabling users to generate production-ready files via natural language, the company aims to remove the technical hurdles that historically hindered independent craft makers.
